Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Defining cell-type specificity at the transcriptional level in human disease.

Ju W, Greene CS, Eichinger F, Nair V, Hodgin JB, Bitzer M, Lee YS, Zhu Q, Kehata M, Li M, Jiang S, Rastaldi MP, Cohen CD, Troyanskaya OG, Kretzler M.

Genome Res. 2013 Nov;23(11):1862-73. doi: 10.1101/gr.155697.113. Epub 2013 Aug 15.

2.

Human disease: Cell types in profile.

Flintoft L.

Nat Rev Genet. 2013 Oct;14(10):678. doi: 10.1038/nrg3580. Epub 2013 Sep 11. No abstract available.

PMID:
24022698
3.

Fn14 in podocytes and proteinuric kidney disease.

Sanchez-Niño MD, Poveda J, Sanz AB, Mezzano S, Carrasco S, Fernandez-Fernandez B, Burkly LC, Nair V, Kretzler M, Hodgin JB, Ruiz-Ortega M, Selgas R, Egido J, Ortiz A.

Biochim Biophys Acta. 2013 Dec;1832(12):2232-43. doi: 10.1016/j.bbadis.2013.08.010. Epub 2013 Aug 30.

4.

The pathogenic role of Notch activation in podocytes.

Niranjan T, Murea M, Susztak K.

Nephron Exp Nephrol. 2009;111(4):e73-9. doi: 10.1159/000209207. Epub 2009 Mar 17. Review.

5.

Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.

Maruschke M, Reuter D, Koczan D, Hakenberg OW, Thiesen HJ.

BJU Int. 2011 Jul;108(2 Pt 2):E29-35. doi: 10.1111/j.1464-410X.2010.09794.x. Epub 2011 Mar 16.

PMID:
21435154
6.

Large-scale identification of genes implicated in kidney glomerulus development and function.

Takemoto M, He L, Norlin J, Patrakka J, Xiao Z, Petrova T, Bondjers C, Asp J, Wallgard E, Sun Y, Samuelsson T, Mostad P, Lundin S, Miura N, Sado Y, Alitalo K, Quaggin SE, Tryggvason K, Betsholtz C.

EMBO J. 2006 Mar 8;25(5):1160-74. Epub 2006 Feb 23.

7.

Renal Gene Expression Database (RGED): a relational database of gene expression profiles in kidney disease.

Zhang Q, Yang B, Chen X, Xu J, Mei C, Mao Z.

Database (Oxford). 2014 Sep 24;2014. pii: bau092. doi: 10.1093/database/bau092. Print 2014.

8.

How are podocytes affected in nail-patella syndrome?

Witzgall R.

Pediatr Nephrol. 2008 Jul;23(7):1017-20. doi: 10.1007/s00467-007-0714-9. Epub 2008 Feb 6.

9.

Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders.

Lasagni L, Ballerini L, Angelotti ML, Parente E, Sagrinati C, Mazzinghi B, Peired A, Ronconi E, Becherucci F, Bani D, Gacci M, Carini M, Lazzeri E, Romagnani P.

Stem Cells. 2010 Sep;28(9):1674-85. doi: 10.1002/stem.492.

10.

The intermediate filament nestin is highly expressed in normal human podocytes and podocytes in glomerular disease.

Perry J, Ho M, Viero S, Zheng K, Jacobs R, Thorner PS.

Pediatr Dev Pathol. 2007 Sep-Oct;10(5):369-82.

PMID:
17929992
11.

Activation of Galpha q-coupled signaling pathways in glomerular podocytes promotes renal injury.

Wang L, Fields TA, Pazmino K, Dai Q, Burchette JL, Howell DN, Coffman TM, Spurney RF.

J Am Soc Nephrol. 2005 Dec;16(12):3611-22. Epub 2005 Nov 2. Erratum in: J Am Soc Nephrol. 2013 Dec;24(12):2126.

12.

HIV-associated nephropathy: experimental models.

Avila-Casado C, Fortoul TI, Chugh SS.

Contrib Nephrol. 2011;169:270-85. doi: 10.1159/000320212. Epub 2011 Jan 20.

PMID:
21252526
13.

Out on a LIM: chronic kidney disease, podocyte phenotype and the Wilm's tumor interacting protein (WTIP).

Sedor JR, Madhavan SM, Kim JH, Konieczkowski M.

Trans Am Clin Climatol Assoc. 2011;122:184-97.

14.

Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation.

Mallipattu SK, Liu R, Zheng F, Narla G, Ma'ayan A, Dikman S, Jain MK, Saleem M, D'Agati V, Klotman P, Chuang PY, He JC.

J Biol Chem. 2012 Jun 1;287(23):19122-35. doi: 10.1074/jbc.M112.345983. Epub 2012 Apr 9.

15.

Cell cycle regulatory proteins in podocyte health and disease.

Marshall CB, Shankland SJ.

Nephron Exp Nephrol. 2007;106(2):e51-9. Epub 2007 Jun 6. Review.

PMID:
17570940
16.

Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis.

Asano T, Niimura F, Pastan I, Fogo AB, Ichikawa I, Matsusaka T.

J Am Soc Nephrol. 2005 Aug;16(8):2257-62. Epub 2005 Jun 29.

17.

Identification of anchor genes during kidney development defines ontological relationships, molecular subcompartments and regulatory pathways.

Thiagarajan RD, Georgas KM, Rumballe BA, Lesieur E, Chiu HS, Taylor D, Tang DT, Grimmond SM, Little MH.

PLoS One. 2011 Feb 28;6(2):e17286. doi: 10.1371/journal.pone.0017286.

18.

Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.

Sonneveld R, Ferrè S, Hoenderop JG, Dijkman HB, Berden JH, Bindels RJ, Wetzels JF, van der Vlag J, Nijenhuis T.

Am J Pathol. 2013 Apr;182(4):1196-204. doi: 10.1016/j.ajpath.2012.12.011. Epub 2013 Feb 4.

19.

A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes.

Ratelade J, Arrondel C, Hamard G, Garbay S, Harvey S, Biebuyck N, Schulz H, Hastie N, Pontoglio M, Gubler MC, Antignac C, Heidet L.

Hum Mol Genet. 2010 Jan 1;19(1):1-15. doi: 10.1093/hmg/ddp462. Epub .

20.

Inducible rodent models of acquired podocyte diseases.

Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, Krofft RD, Logar CM, Marshall CB, Ohse T, Shankland SJ.

Am J Physiol Renal Physiol. 2009 Feb;296(2):F213-29. doi: 10.1152/ajprenal.90421.2008. Epub 2008 Sep 10. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk